Jean-François Sarrazin, Jamal Laaouaj, François Philippon, Marina Sanchez, Philippe Gervais, Jean Champagne, Christian Steinberg, Isabelle Nault, Karine Roy, Benoît Plourde, Louis Blier, Gilles O'Hara
Background: Cephalosporins are the cornerstone of cardiac device infection prophylaxis. Owing to fears of cross-reactivity, penicillin-allergic patients are exposed to potentially more-toxic drugs, with decreased efficacy. We evaluated the safety of a cefazolin test dose (CTD) in self-reported penicillin-allergic patients. Methods: In this single-centre study, we evaluated consecutive patients with chart documentation of penicillin allergy undergoing cardiac device implantation, over a 2-year period...
August 2022: CJC open